IMDX
Insight Molecular Diagnostics
IMDX
IMDX
56 hedge funds and large institutions have $67.8M invested in Insight Molecular Diagnostics in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 56 → 56 (0)
0.05% less ownership
Funds ownership: 2.27% → 2.22% (-0.05%)
Holders
56
Holding in Top 10
2
Calls
$1K
Puts
–
Top Buyers
| 1 | +$3.41M | |
| 2 | +$628K | |
| 3 | +$296K | |
| 4 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
+$245K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$103K |
Top Sellers
| 1 | -$290K | |
| 2 | -$154K | |
| 3 | -$77.3K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$77K |
| 5 |
Morgan Stanley
New York
|
-$71.1K |